Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas
  2. Barreca, Marilia; Spanò, Virginia; Rocca, Roberta; Bivacqua, Roberta; Gualtieri, Gianmarco; Raimondi, Maria Valeria; Gaudio, Eugenio; Bortolozzi, Roberta; Manfreda, Lorenzo; Bai,Ruoli; Montalbano, Alessandra; Alcaro, Stefano; Hamel,Ernest; Bertoni, Francesco; Viola, Giampietro; Barraja, Paola
  3. European Journal of Medicinal Chemistry. 2023, Apr 12; 254: 115372.
  1. 2.   Chemically Programmable and Switchable CAR-T Therapy
  2. Qi, Junpeng; Tsuji, Kohei; Hymel, David; Burke,Terrence; Hudecek, Michael; Rader, Christoph; Peng, Haiyong
  3. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2020, MAY 18;
  1. 3.   Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors
  2. Leese, M. P.; Jourdan, F.; Dohle, W.; Kimberley, M. R.; Thomas, M. P.; Bai, R. L.; Hamel, E.; Ferrandis, E.; Potter, B. V. L.
  3. Acs Medicinal Chemistry Letters. 2012, Jan; 3(1): 5-9.
  1. 4.   Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors [1]
  2. Andreani, A.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Lannigan, D.; Smith, J.; Scudiero, D.; Kondapaka, S.; Shoemaker, R. H.
  3. European Journal of Medicinal Chemistry. 2011, Sep; 46(9): 4311-4323.
  1. 5.   Synthesis and Anticancer Activity of 13-Membered Cyclic Enediynes
  2. Sharma, M.; Joshi, M. C.; Kumar, V.; Malhotra, S. V.; Rawat, D. S.
  3. Archiv Der Pharmazie. 2011, Sep; 344(9): 564-571.
  1. 6.   Synthesis and Biological Evaluation of ABCD Ring Fragments of the Kibdelones
  2. Sloman, D. L.; Mitasev, B.; Scully, S. S.; Beutler, J. A.; Porco, J. A.
  3. Angewandte Chemie-International Edition. 2011, Mar 7; 50(11): 2511-2515.
  1. 7.   Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance
  2. Gangjee, A.; Zhao, Y.; Lin, L.; Raghavan, S.; Roberts, E. G.; Risinger, A. L.; Hamel, E.; Mooberry, S. L.
  3. Journal of Medicinal Chemistry. 2010, Nov; 53(22): 8116-8128.
  1. 8.   Synthesis and Evaluation of Haloacetyl, alpha-Bromoacryloyl and Nitrooxyacetyl Benzo[b]furan and Benzo[b]thiophene Derivatives as Potent Antiproliferative Agents Against Leukemia L1210 and K562 Cells
  2. Romagnoli, R.; Baraldi, P. G.; Carrion, M. D.; Cara, C. L.; Casolari, A.; Hamel, E.; Fabbri, E.; Gambari, R.
  3. Letters in Drug Design & Discovery. 2010, Aug; 7(7): 476-486.
  1. 9.   Antitumor agents 273. Design and synthesis of N-alkyl-thiocolchicinoids as potential antitumor agents
  2. Kozaka, T.; Nakagawa-Goto, K.; Shi, Q. A.; Lai, C. Y.; Hamel, E.; Bastow, K. F.; Brossi, A.; Lee, K. H.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, Jul; 20(14): 4091-4094.
  1. 10.   High Throughput Extraction of Plant, Marine and Fungal Specimens for Preservation of Biologically Active Molecules
  2. McCloud, T. G.
  3. Molecules. 2010, Jul; 15(7): 4526-4563.
  1. 11.   Symmetrical alpha-bromoacryloylamido diaryldienone derivatives as a novel series of antiproliferative agents. Design, synthesis and biological evaluation
  2. Romagnoli, R.; Baraldi, P. G.; Cruz-Lopez, O.; Cara, C. L.; Carrion, M. D.; Balzarini, J.; Hamel, E.; Basso, G.; Bortolozzi, R.; Viola, G.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, May; 20(9): 2733-2739.
  1. 12.   Synthesis, Antitubulin, and Antiproliferative SAR of Analogues of 2-Methoxyestradiol-3,17-O,O-bis-sulfamate
  2. Jourdan, F.; Leese, M. P.; Dohle, W.; Hamel, E.; Ferrandis, E.; Newman, S. P.; Purohit, A.; Reed, M. J.; Potter, B. V. L.
  3. Journal of Medicinal Chemistry. 2010, Apr; 53(7): 2942-2951.
  1. 13.   Synthesis and Biological Evaluation of 2-aroyl-4-phenyl-5-hydroxybenzofurans as a New Class of Antitubulin Agents
  2. Romagnoli, R.; Baraldi, P. G.; Sarkar, T.; Cara, C. L.; Lopez, O. C.; Carrion, M. D.; Preti, D.; Tolomeo, M.; Balzarini, J.; Hamel, E.
  3. Medicinal Chemistry. 2008 4(6): 558-564.
  1. 14.   Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1 alpha protein accumulation by NSC 644221
  2. Creighton-Gutteridge, M.; Cardellina, J. H.; Stephen, A. G.; Rapisarda, A.; Uranchimeg, B.; Hite, K.; Denny, W. A.; Shoemaker, R. H.; Melillo, G.
  3. Clinical Cancer Research. 2007, Feb; 13(3): 1010-1018.
  1. 15.   Identification of a new natural camptothecin analogue in targeted screening for HIF-1 alpha inhibitors
  2. Klausmeyer, P.; McCloud, T. G.; Melillo, G.; Scudiero, D. A.; Cardellina, J. H.; Shoemaker, R. H.
  3. Planta Medica. 2007, Jan; 73(1): 49-52.
  1. 16.   Synthesis and biological evaluation of bisindenoisoquinolines as topoisomerase I inhibitors
  2. Nagarajan, M.; Morrell, A.; Antony, S.; Kohlhagen, G.; Agama, K.; Pommier, Y.; Ragazzon, P. A.; Garbett, N. C.; Chaires, J. B.; Hollingshead, M.; Cushman, M.
  3. Journal of Medicinal Chemistry. 2006, Aug; 49(17): 5129-5140.
  1. 17.   A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach
  2. Nguyen, T. L.; McGrath, C.; Hermone, A. R.; Burnett, J. C.; Zaharevitz, D. W.; Day, B. W.; Wipf, P.; Hamel, E.; Gussio, R.
  3. Journal of Medicinal Chemistry. 2005, SEP 22; 48(19): 6107-6116.
  1. 18.   A new synthetic agent with potent but selective cytotoxic activity against cancer
  2. Cholody, W. M.; Kosakowska-Cholody, T.; Hollingshead, M. G.; Hariprakasha, H. K.; Michejda, C. J.
  3. Journal of Medicinal Chemistry. 2005, JUN 30; 48(13): 4474-4481.
  1. 19.   Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-4
  2. Pettit, G. R.; Rhodes, M. R.; Herald, D. L.; Hamel, E.; Schmidt, J. M.; Pettitt, R. K.
  3. Journal of Medicinal Chemistry. 2005, JUN 16; 48(12): 4087-4099.
  1. 20.   Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin
  2. Shi, Y. H.; Song, Y. L.; Lin, D. H.; Tan, J. Z.; Roller, P. P.; Li, Q.; Long, Y. Q.; Song, G. Q.
  3. Biochemical and Biophysical Research Communications. 2005, MAY 20; 330(4): 1254-1261.
  1. 21.   The search for novel drug leads for predominately antitumor therapies by utilizing mother nature's pharmacophoric libraries
  2. Kingston, D. G. I.; Newman, D. J.
  3. Current Opinion in Drug Discovery & Development. 2005, MAR; 8(2): 207-227.
  1. 22.   Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines
  2. Simoni, D.; Grisolia, G.; Giannini, G.; Roberti, M.; Rondanin, R.; Piccagli, L.; Baruchello, R.; Rossi, M.; Romagnoli, R.; Invidiata, F. P.; Grimaudo, S.; Jung, M. K.; Hamel, E.; Gebbia, N.; Crosta, L.; Abbadessa, V.; Di Cristina, A.; Dusonchet, L.; Meli, M.; Tolomeo, M.
  3. Journal of Medicinal Chemistry. 2005, FEB 10; 48(3): 723-736.
  1. 23.   Antitumor agents. Part 236: Synthesis of water-soluble colchicine derivatives
  2. Nakagawa-Goto, K.; Chen, C. X.; Hamel, E.; Wu, C. C.; Bastow, K. F.; Brossi, A.; Lee, K. H.
  3. Bioorganic & Medicinal Chemistry Letters. 2005, JAN 3; 15(1): 235-238.
  1. 24.   The experimental antitumor agents Phortress and Doxorubicin are equiactive against human-derived breast carcinoma xenograft models
  2. Fichtner, I.; Monks, A.; Hose, C.; Stevens, M. F. G.; Bradshaw, T. D.
  3. Breast Cancer Research and Treatment. 2004, SEP; 87(1): 97-107.
  1. 25.   6-alkylamino- and 2,3-dihydro-3 '-methoxy-2-phenyl-4- quinazolinones and related compounds: Their synthesis, cytotoxicity, and inhibition of tubulin polymerization
  2. Hour, M. J.; Huang, L. J.; Kuo, S. C.; Xia, Y.; Bastow, K.; Nakanishi, Y.; Hamel, E.; Lee, K. H.
  3. Journal of Medicinal Chemistry. 2000 43(23): 4479-4487.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel